Pantethine therapy dramatically rescues end-stage failing heart in a patient with deficiency of coenzyme A biosynthesis
- PMID: 40196914
- PMCID: PMC12287790
- DOI: 10.1002/ehf2.15283
Pantethine therapy dramatically rescues end-stage failing heart in a patient with deficiency of coenzyme A biosynthesis
Keywords: Metabolic therapy; PPCS deficiency; Vitamin B5 (pantothenate).
Conflict of interest statement
FL reports consulting fees from AlfaSigma, Biomarin and Sanofi Genzyme, outside the submitted work. The other authors reported no conflict of interest.
Figures
References
-
- Lok A, Fernandez‐Garcia MA, Taylor RW, French C, MacFarland R, Bodi I, et al. Novel phosphopantothenoylcysteine synthetase (PPCS) mutations with prominent neuromuscular features: expanding the phenotypical spectrum of PPCS‐related disorders. Am J Med Genet A 2022;188:2783–2789. doi: 10.1002/ajmg.a.62848 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
